4th Quarter - Report
FEDERAL HEALTH POLICY STRATEGIES for PFIZER
Client
Income
$60,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Drug pricing reform H.R. 3--Elijah E. Cummings Lower Drug Costs Now Act Biosimilar utilization policy S.912/H.R. 1978--the Protecting Seniors Through Immunization Act of 2021 H.R. 197--Federal Accountability in Chemical Testing Act or the FACT Act S.91 - Special Districts Provide Essential Services Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAN ELLING | — |
| COLIN ROSKEY | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.